| Citation: |
XU Jisheng, ZHAO Xuan, ZHOU Bing, CHAI Haiquan, MA Shumin, ZHANG Shenglin, LI Jie, ZHOU Jian, ZHOU Zichun, DIAO Qixian. Medication rules of traditional Chinese medicine in treatment of thyroid nodules based on real-world data analysis[J]. Journal of Clinical Medicine in Practice, 2024, 28(4): 25-28, 33. DOI: 10.7619/jcmp.20232663
|
To analyze medication rules of traditional Chinese medicine in the treatment of thyroid nodules based on real-world data mining technology.
Chinese medicine prescriptions for patients with thyroid nodules as clinical first diagnosis in the Department of Thyroid and Breast Surgery in Qingdao Hospital of Traditional Chinese Medicine from August 2018 to August 2023 were collected, and the Traditional Chinese Medicine Inheritance Assistant Platform (V3.0) was used to analyze the medication rules.
A total of 1 206 traditional Chinese medicine prescriptions for the treatment of thyroid nodules were screened, involving 291 traditional Chinese medicines; the top five most frequently used drugs were Fritillaria thunbergii, Prunella vulgaris, Bupleurum chinense, Poria cocos, and Pinellia ternata; the main function of drugs were clearing heat, tonifying deficiency, resolving phlegm, activating blood circulation, and regulating qi; the main property of the drugs was cold, the main tastes of drugs were bitter, sweet and spicy, and the meridians involved were mainly the lung, liver and spleen meridians; association rule analysis identified 17 high-frequency drug combinations, with Fritillaria thunbergii-Prunella vulgaris as the most frequently occurring drug pair; among the 16 association rules, Radix Scrophulariae-Fritillaria thunbergii and Rhizoma Cyperi-Bupleurum chinense had the highest confidence level; clustering analysis found 6 core drug combinations.
The main idea of clinical treatment of thyroid nodules in traditional Chinese medicine is to resolve phlegm and reduce nodules, promote qi circulation and blood circulation, and nourish qi and blood; the common herbal combination of Fritillaria thunbergii and Prunella vulgaris is used to clear heat, resolve phlegm, and reduce nodules, and the basic formula for resolving scrofula is based on Xiaoluo Pills, which resolves phlegm, softens hardened nodules, and reduces nodules.
| [1] |
高天舒, 倪青. 甲状腺结节病证结合诊疗指南(2022)[J]. 中医杂志, 2023, 64(4): 425-432. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202304020.htm
|
| [2] |
张启暝, 董晓秋, 王思明, 等. 居民碘营养状况及甲状腺结节的危险因素分析[J]. 中国超声医学杂志, 2021, 37(2): 128-131. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCY202102004.htm
|
| [3] |
马微, 袁绍祺, 杨少伟, 等. 江西省放射工作人员甲状腺功能及甲状腺结节检出情况分析[J]. 中国工业医学杂志, 2021, 34(4): 358-361. https://www.cnki.com.cn/Article/CJFDTOTAL-SOLE202104026.htm
|
| [4] |
王伟. 脂代谢异常人群甲状腺结节的检出情况及相关影响因素研究[J]. 检验医学与临床, 2022, 19(19): 2704-2707. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYL202219030.htm
|
| [5] |
鞠香丽, 裴冬梅. 甲状腺结节患病率与血糖、血脂代谢异常的相关性研究[J]. 实用临床医药杂志, 2020, 24(10): 53-56. doi: 10.7619/jcmp.202010013
|
| [6] |
季明, 张楷, 邹子鸣, 等. 6096例健康体检教师人群甲状腺结节检出率及影响因素分析[J]. 南京医科大学学报: 自然科学版, 2022, 42(9): 1287-1293. https://www.cnki.com.cn/Article/CJFDTOTAL-NJYK202209014.htm
|
| [7] |
伍朝春, 黄政德, 庞羽, 等. 广西地区67990例体检人群甲状腺结节检出情况及危险因素分析[J]. 广东医学, 2022, 43(8): 930-933. https://www.cnki.com.cn/Article/CJFDTOTAL-GAYX202208002.htm
|
| [8] |
赵秋玲, 汪周天, 许平, 等. 深圳市某院体检人群甲状腺结节检出率及其关联因素[J]. 现代预防医学, 2021, 48(14): 2681-2684. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF202114042.htm
|
| [9] |
葛鹏, 王镁. 中医药治疗甲状腺结节的现状评述[J]. 中国医学创新, 2022, 19(11): 183-188. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYCX202211045.htm
|
| [10] |
杨萍, 王海军, 王少莲, 等. 中医药治疗良性单纯性甲状腺结节临床疗效的Meta分析[J]. 湖北中医杂志, 2022, 44(3): 56-63. https://www.cnki.com.cn/Article/CJFDTOTAL-HBZZ202203016.htm
|
| [11] |
中国内分泌代谢病专科联盟. 甲状腺结节诊治行业标准[J]. 中华内分泌代谢杂志, 2022, 38(7): 552-554.
|
| [12] |
Thyroid Committee of Shanghai Association of Chinese Integrative Medicine; Thyroid Tumor Ablation Experts Croup of Chinese Medical Doctor Association. 《甲状腺结节及相关疾病热消融中西医结合诊疗指南》(2021版)[J]. 中国卫生标准管理, 2022, 13(7): 1-7. https://www.cnki.com.cn/Article/CJFDTOTAL-WSBZ202207051.htm
|
| [13] |
国家药典委员会. 中华人民共和国药典(2020年版)[M]. 北京: 中国医药科技出版社, 2020: 1-31.
|
| [14] |
孙禹, 梁伟. 浙贝母的化学成分、药理作用及临床应用研究进展[J]. 特产研究, 2022, 44(1): 87-92. https://www.cnki.com.cn/Article/CJFDTOTAL-TCYA202201014.htm
|
| [15] |
覃昕怡, 张泽南, 张帅, 等. 夏枯草中主要化学成分群的时空积累及抗氧化活性的动态变化研究[J]. 中医药导报, 2023, 29(3): 62-67. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZB202303011.htm
|
| [16] |
陈蕾, 卢泽容, 黄雨晴, 等. 夏枯草有效成分对儿童甲状腺癌的抑制作用研究[J]. 发育医学电子杂志, 2022, 10(4): 241-249. https://www.cnki.com.cn/Article/CJFDTOTAL-FYYD202204001.htm
|
| [17] |
李永桂, 管昱鑫, 李小鸾, 等. 夏枯草汤加减结合雷火神针治疗良性甲状腺结节(气郁痰阻型)临床效果观察[J]. 中华中医药学刊, 2022, 40(8): 225-228. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202208053.htm
|
| [18] |
刘家斌, 杨云梅, 侯宁. 夏枯草颗粒对桥本甲状腺炎合并甲状腺结节手术患者围术期促炎与抗炎状态的影响研究[J]. 海军医学杂志, 2021, 42(5): 614-616. https://www.cnki.com.cn/Article/CJFDTOTAL-HJYX202105025.htm
|
| [19] |
徐玉林, 史传文. 夏枯草胶囊干预结节性甲状腺肿术后复发的研究进展[J]. 江西中医药, 2022, 53(12): 78-80. https://www.cnki.com.cn/Article/CJFDTOTAL-JXZY202212025.htm
|
| [20] |
周杨晶. 从"气、痰、瘀、虚"论治甲状腺结节临证经验[J]. 中国民族民间医药, 2021, 30(16): 77-79. https://www.cnki.com.cn/Article/CJFDTOTAL-MZMJ202116022.htm
|
| 1. |
王振豪，周世勇. 西药联合理气散结中药汤治疗甲状腺结节的疗效及对甲状腺功能指标的影响. 内蒙古中医药. 2025(01): 21-23 .
| |
| 2. |
陈露菲，李丽，麻金叶. 针灸配合白芥子汤加减治疗甲状腺结节的临床效果及对甲状腺功能的影响. 临床合理用药. 2024(34): 107-110 .
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: